H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) shares crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares.
H. Lundbeck A/S Stock Down 0.0%
The firm has a market capitalization of $21.91 billion, a price-to-earnings ratio of 25.00 and a beta of 0.68. The business’s 50 day moving average is $22.00 and its 200-day moving average is $22.00. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.71 and a current ratio of 1.15.
About H. Lundbeck A/S
H. Lundbeck A/S is a Denmark-based pharmaceutical company focused on developing, manufacturing and commercializing medicines for brain diseases. Its research and commercial activities address conditions including depression, schizophrenia, migraine, alcohol dependence and other neurological and psychiatric disorders.
The company’s portfolio includes Vyepti (eptinezumab) for the preventive treatment of migraine, Trintellix (vortioxetine) for major depressive disorder, Rexulti (brexpiprazole) for selected psychiatric indications, and Abilify Maintena (aripiprazole) for the treatment of schizophrenia and maintenance treatment of bipolar I disorder.
See Also
- Five stocks we like better than H. Lundbeck A/S
- Aeluma’s Selloff Could Be Setting Up Its Next Big Move
- Crypto Bill Stalls, Smart Money Calls: Time to Buy the Dip?
- The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks
- The Fed’s Rate Hike Could Backfire If Oil Prices Collapse
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
